tiprankstipranks
Trending News
More News >
Jiutian Chemical Group Limited (SG:C8R)
:C8R
Singapore Market
Advertisement

Jiutian Chemical Group Limited (C8R) AI Stock Analysis

Compare
8 Followers

Top Page

SG:C8R

Jiutian Chemical Group Limited

(SGX:C8R)

Rating:43Neutral
Price Target:
S$0.00
▼(-100.00%Downside)
Jiutian Chemical Group Limited's overall stock score is primarily influenced by its poor financial performance, which is the most significant factor. Technical analysis provides some short-term positive momentum, but the extremely high RSI suggests potential overvaluation. The negative P/E ratio highlights serious valuation concerns, further impacting the score negatively. With no earnings call insights or corporate events to adjust the analysis, the stock's outlook remains challenging.

Jiutian Chemical Group Limited (C8R) vs. iShares MSCI Singapore ETF (EWS)

Jiutian Chemical Group Limited Business Overview & Revenue Model

Company DescriptionJiutian Chemical Group Limited (C8R) is a Singapore-based company primarily engaged in the manufacturing and distribution of chemical products. The company operates in the industrial chemical sector, focusing on the production of dimethylformamide (DMF) and methylamine, which are widely used as industrial solvents and in the manufacturing of various products. Jiutian Chemical's operations are based in China, where it leverages local resources and expertise to maintain a competitive edge in the chemical manufacturing industry.
How the Company Makes MoneyJiutian Chemical Group Limited generates revenue through the production and sale of its core chemical products, dimethylformamide (DMF) and methylamine. These chemicals are essential components in multiple industries, including pharmaceuticals, agriculture, textiles, and electronics, serving as solvents and intermediates in manufacturing processes. The company earns money by selling these products directly to industrial customers and distributors who require them for their manufacturing needs. Additionally, Jiutian Chemical may engage in partnerships or supply agreements with other industrial players, which can provide stable and recurring revenue streams. Factors such as global demand for chemicals, raw material costs, and production efficiency significantly impact the company's earnings.

Jiutian Chemical Group Limited Financial Statement Overview

Summary
Jiutian Chemical Group Limited is facing significant financial difficulties, with declining revenue, profitability, and cash flow. The income statement reveals critical weaknesses in generating profits, while the balance sheet indicates moderate leverage but declining equity. Cash flow challenges further exacerbate the company's financial instability, raising concerns about its ability to sustain operations without strategic interventions.
Income Statement
15
Very Negative
Jiutian Chemical Group Limited has experienced a significant decline in revenue and profitability over the past years. The gross profit margin and net profit margin have turned negative, indicating that the company is not covering its costs. The revenue growth rate has decreased significantly, with a notable drop in total revenue from 2022 to 2023. EBIT and EBITDA margins are also negative, highlighting poor operational performance. Overall, the company's income statement presents substantial financial challenges.
Balance Sheet
40
Negative
The balance sheet of Jiutian Chemical Group Limited shows moderate leverage with a debt-to-equity ratio that has improved slightly over the years. However, the equity ratio has decreased, indicating a decline in the proportion of assets financed by equity. Return on Equity (ROE) has become negative due to consecutive net losses. Although cash reserves are relatively strong, the overall stability is compromised by declining equity and profitability.
Cash Flow
20
Very Negative
The cash flow situation is concerning, with free cash flow experiencing a negative growth rate and operating cash flow consistently negative over the recent years. The operating cash flow to net income ratio is unfavorable, reflecting inefficiencies in converting income to cash. Free cash flow to net income ratio is also negative, indicating cash flow issues that could impact future operations.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue243.76M598.56M2.43B2.17B1.15B
Gross Profit-82.26M-260.18M708.41M675.62M274.77M
EBITDA-118.22M-321.76M696.61M632.38M259.93M
Net Income-147.80M-344.64M490.50M324.90M173.69M
Balance Sheet
Total Assets1.05B1.29B1.99B1.89B1.43B
Cash, Cash Equivalents and Short-Term Investments400.41M529.62M1.11B773.55M259.73M
Total Debt289.32M265.88M134.64M228.18M344.30M
Total Liabilities427.02M523.23M764.65M1.08B911.93M
Stockholders Equity618.04M765.84M1.22B816.21M524.74M
Cash Flow
Free Cash Flow-171.63M-511.23M424.05M633.54M122.69M
Operating Cash Flow-81.58M-385.65M434.01M655.81M129.02M
Investing Cash Flow-89.54M-125.70M-9.85M-27.68M-10.90M
Financing Cash Flow32.87M-732.00K-95.52M-110.89M5.67M

Jiutian Chemical Group Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.03
Price Trends
50DMA
0.02
Positive
100DMA
0.02
Positive
200DMA
0.03
Positive
Market Momentum
MACD
<0.01
Negative
RSI
99.20
Negative
STOCH
116.67
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C8R, the sentiment is Positive. The current price of 0.03 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.03, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 99.20 is Negative, neither overbought nor oversold. The STOCH value of 116.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C8R.

Jiutian Chemical Group Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.49B10.771.52%2.68%2.24%-33.79%
43
Neutral
S$53.69M-21.30%-60.43%57.93%
S$41.77M5.85-17.75%2.73%
S$53.32M6.7514.57%2.50%
S$54.32M134.550.37%3.38%
S$52.45M23.563.88%5.08%
S$33.12M-10.42%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C8R
Jiutian Chemical Group Limited
0.03
<0.01
50.00%
SG:C05
Chemical Industries Far East Ltd.
0.54
0.05
10.20%
SG:5DS
MegaChem Ltd.
0.40
-0.02
-4.76%
SG:A55
Asia Enterprises Holding Ltd.
0.16
0.03
23.08%
SG:BEI
LHT Holdings Ltd
0.98
0.08
8.89%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.10
0.00
0.00%

Jiutian Chemical Group Limited Corporate Events

Jiutian Chemical Faces Arbitration Over Subsidiary Investment Loss
Jul 7, 2025

Jiutian Chemical Group Limited has received a notice of arbitration from a minority shareholder of its former subsidiary, Changzhou Jiutian Xiean Chemical Co., Ltd, which is undergoing creditor’s voluntary liquidation. The arbitration, filed with the Shanghai International Arbitration Center, involves a compensation claim of RMB 2 million for alleged investment losses. The company is reviewing the claim with legal advisors and will update shareholders on any significant developments, advising caution in dealing with its securities.

Jiutian Chemical Extends Long-Stop Date for Synthetic Ammonia Project
Jun 25, 2025

Jiutian Chemical Group Limited has announced a third extension of the Long-Stop Date for its Framework Agreement and Synthetic Ammonia Project Transfer Agreement with Anyang Chemical Industry Group Co., Ltd. The extension, now set for December 31, 2025, is necessary to fulfill certain conditions precedent. The company has not reported significant developments since its last update and advises shareholders to exercise caution with their securities.

Jiutian Chemical Group Holds Twentieth AGM
May 19, 2025

Jiutian Chemical Group Limited held its Twentieth Annual General Meeting at Voco Orchard Singapore, where the Board of Directors and key company officials were present. The meeting was chaired by Executive Director Mr. Lee Chee Seng and addressed shareholder questions regarding resolutions, with responses published on SGXNet prior to the meeting.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 26, 2025